Two Sigma Securities’s Envoy Medical COCH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15.4K Sell
23,121
-4,535
-16% -$3.09K ﹤0.01% 1412
2025
Q4
$18.3K Buy
+27,656
New +$21.9K ﹤0.01% 1193
2023
Q4
Sell
-12,224
Closed -$85.8K 3100
2023
Q3
$85.8K Buy
+12,224
New +$122K ﹤0.01% 2414

Other funds holding COCH

Two Sigma Securities's COCH Position: Q1 2026 in Review

Two Sigma Securities reduced its Envoy Medical (COCH) stake by 16% in Q1 2026, selling an estimated $3.09K and leaving 23,121 shares worth $15.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1412.

Two Sigma Securities first reported a position in COCH in Q3 2023 and has held it in 3 quarters since. The position peaked at $85.8K in Q3 2023. 33 funds tracked by Wall St. Rank hold COCH as of Q1 2026.

  • Two Sigma Securities held 23,121 shares of Envoy Medical worth $15.4K as of Q1 2026.
  • Two Sigma Securities sold 4,535 Envoy Medical shares in Q1 2026, an estimated $3.09K.
  • Envoy Medical made up ﹤0.01% of Two Sigma Securities's portfolio in Q1 2026, its #1412 holding.
  • Two Sigma Securities first reported a position in Envoy Medical in Q3 2023 and has held it in 3 quarters since.
  • Two Sigma Securities's Envoy Medical position peaked at $85.8K in Q3 2023.
  • 33 funds tracked by Wall St. Rank held Envoy Medical as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.